Results 81 to 90 of about 3,928,328 (244)

Content of the active pharmaceutical ingredient determined for each sample.

open access: yes, 2018
Content of the active pharmaceutical ingredient determined for each sample.
Emmanuel Wemakor (6029687)   +3 more
core   +1 more source

Hydration Behavior of Tricalcium Silicate in Seawater Relevant Salt Systems: A Hybrid Study with the Aid of Machine Learning

open access: yesAdvanced Intelligent Discovery, EarlyView.
The hydration behavior of C3S in seawater‐relevant solutions is studied based on experiments, boundary nucleation and growth (BNG) modeling, and machine learning. The main ions included in seawater modify hydration mechanisms, with MgCl2 showing the strongest acceleration effect at the same concentration.
Yanjie Sun   +6 more
wiley   +1 more source

Evaluation of the Quality Parameters of Anti-flu Combinations Containing Phenylephrine Hydrochloride Available in the Brazilian Market

open access: yesOrbital: The Electronic Journal of Chemistry
The combination of different active substances in drug products is responsible for optimizing therapies and improving patient adherence. However, the development process of these formulations is highly challenging due to differences in the ...
Diana La Luna Bissetti Costa   +7 more
doaj   +1 more source

Multimodal Learning with Rashomon Analysis for Battery Discharge Capacity Prediction

open access: yesAdvanced Intelligent Discovery, EarlyView.
Multimodal fusion integrates composition, crystal‐structure, and radial‐distribution descriptors to predict battery discharge capacity. Rashomon analysis across near‐optimal models reveals that explanatory variation is structured rather than arbitrary, separating stable mechanistic signals from model‐contingent attributions and providing a more ...
Jue Gong   +4 more
wiley   +1 more source

Crystallization of active pharmaceutical ingredient on substrates

open access: yes, 2014
Due to the demand of individualized pharmaceutical formulation, the application of drop printing (DP) technology on manufacturing of pharmaceutical devices has received extensive attention.
Hsu, Hsin-Yun
core   +1 more source

Excipients used in nano-technology assisted drug delivery systems

open access: yesJournal of Excipients and Food Chemicals, 2016
The overall therapeutic benefit of an active pharmaceutical ingredient (API) is dependent on its potency and efficacy to deliver to the site of action.
Arvind Kumar Bansal
doaj  

Determination of the shelf life of the API morpholinium 2-((4-(2-methoxyphenyl)-5-(4-pyridyl)-4H-1,2,4-triazol-3-yl)thio)acetate

open access: yesAktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki
This study determined the shelf life of the active pharmaceutical ingredient (API) morpholinium 2-(4-(2-methoxyphenyl)-5-(4-pyridyl)-4H-1,2,4-triazol-3-yl)thio)acetate by determining its quantitative storage characteristics. Aim.
A. H. Kaplaushenko   +3 more
doaj   +1 more source

Tracking of Physicochemical Properties in Free Films Containing an API

open access: yes, 2010
Coated dosage forms in which the active pharmaceutical ingredient (API) is incorporated in the film layer in order to achieve rapid release have become very common in recent years.
K. PINTYE-HÓDI   +4 more
core   +1 more source

Nanostructured Deep Eutectic Systems in Healthcare: From Bioactive Solvents to Intelligent Biointerfaces, Wearables, and AI‐Driven Design

open access: yesAdvanced NanoBiomed Research, EarlyView.
Beyond the green solvent paradigm, this review redefines Deep Eutectic Systems (DES) as programmable supramolecular nanoassemblies. We survey their biomedical convergence: stabilizing thermolabile mRNA to enable cold chain‐free logistics, reshaping transdermal microneedle delivery, enabling long‐term wearables via eutectogels, and utilizing Generative ...
Jeesu Moon, Min Seo Kim, Jae‐Seung Lee
wiley   +1 more source

Polybenzimidazole for Active Pharmaceutical Ingredient Purification: The Mometasone Furoate Case Study

open access: yes, 2019
Active pharmaceutical ingredient (API) purity is of major concern for pharmaceutical companies and the medical community. Reaching ultralow limits of genotoxic impurities (GTIs), imposed by strict legislation, is often time consuming and economically ...
Frederico Castelo Ferreira   +11 more
core   +1 more source

Home - About - Disclaimer - Privacy